Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.750
-0.030 (-1.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
Puma Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 67.26 | 84.59 | 76.2 | 63.13 | 85.29 | 60.04 | Upgrade
|
Short-Term Investments | 29.46 | 11.35 | 4.87 | 18.98 | 8.1 | 51.61 | Upgrade
|
Cash & Short-Term Investments | 96.73 | 95.94 | 81.07 | 82.11 | 93.39 | 111.64 | Upgrade
|
Cash Growth | 13.76% | 18.34% | -1.26% | -12.08% | -16.35% | -32.51% | Upgrade
|
Accounts Receivable | 54.64 | 47.84 | 40.35 | 32.53 | 25.54 | 28.9 | Upgrade
|
Other Receivables | - | 0.65 | 1.92 | - | - | - | Upgrade
|
Receivables | 54.64 | 48.49 | 42.27 | 32.53 | 25.54 | 28.9 | Upgrade
|
Inventory | 2.67 | 7.08 | 4.53 | 7.11 | 3.45 | 3.17 | Upgrade
|
Prepaid Expenses | 0.88 | 2.48 | 2.62 | 8.98 | 11.26 | 13.26 | Upgrade
|
Restricted Cash | - | - | - | 8.85 | 8.85 | 8.85 | Upgrade
|
Other Current Assets | 1.9 | 2.19 | 3.79 | 0.45 | 3.64 | 0.48 | Upgrade
|
Total Current Assets | 156.82 | 156.19 | 134.28 | 140.02 | 146.14 | 166.3 | Upgrade
|
Property, Plant & Equipment | 6.02 | 8.65 | 12.51 | 15.77 | 18.89 | 21.83 | Upgrade
|
Other Intangible Assets | 53.57 | 60.87 | 70.61 | 66.13 | 74.14 | 40.46 | Upgrade
|
Long-Term Deferred Charges | 0.17 | 0.21 | - | 0.74 | 0.96 | 0.87 | Upgrade
|
Other Long-Term Assets | 4.15 | 4.62 | 4.66 | 3.92 | 4.1 | 5.45 | Upgrade
|
Total Assets | 220.72 | 230.53 | 222.06 | 226.59 | 244.22 | 234.91 | Upgrade
|
Accounts Payable | 7.51 | 6.89 | 6.44 | 11.17 | 12.08 | 19.18 | Upgrade
|
Accrued Expenses | 33.22 | 35.63 | 32.73 | 24.03 | 29.59 | 29.7 | Upgrade
|
Current Portion of Long-Term Debt | 45.33 | 34 | - | - | 14.29 | - | Upgrade
|
Current Portion of Leases | 5.35 | 4.8 | 4.14 | 3.57 | 3.09 | 2.62 | Upgrade
|
Other Current Liabilities | 18.99 | 18.07 | 34.17 | 70.81 | 55.21 | 39.33 | Upgrade
|
Total Current Liabilities | 110.4 | 99.38 | 77.48 | 109.59 | 114.26 | 90.84 | Upgrade
|
Long-Term Debt | 32.75 | 65.66 | 98.31 | 97.09 | 84.03 | 94.96 | Upgrade
|
Long-Term Leases | 2.95 | 7.03 | 11.83 | 15.98 | 19.55 | 22.64 | Upgrade
|
Other Long-Term Liabilities | 3.54 | 5.01 | 12.83 | 6.38 | 32.34 | 9 | Upgrade
|
Total Liabilities | 149.63 | 177.09 | 200.45 | 229.03 | 250.17 | 217.44 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 1,405 | 1,399 | 1,388 | 1,364 | 1,332 | 1,295 | Upgrade
|
Retained Earnings | -1,334 | -1,345 | -1,367 | -1,367 | -1,338 | -1,278 | Upgrade
|
Comprehensive Income & Other | 0.03 | -0 | - | -0 | - | 0.06 | Upgrade
|
Shareholders' Equity | 71.09 | 53.44 | 21.61 | -2.45 | -5.95 | 17.46 | Upgrade
|
Total Liabilities & Equity | 220.72 | 230.53 | 222.06 | 226.59 | 244.22 | 234.91 | Upgrade
|
Total Debt | 86.37 | 111.49 | 114.28 | 116.64 | 120.95 | 120.23 | Upgrade
|
Net Cash (Debt) | 10.36 | -15.55 | -33.21 | -34.54 | -27.57 | -8.59 | Upgrade
|
Net Cash Per Share | 0.21 | -0.33 | -0.74 | -0.85 | -0.70 | -0.22 | Upgrade
|
Filing Date Shares Outstanding | 49.09 | 48.21 | 46.64 | 41.33 | 40.26 | 39.3 | Upgrade
|
Total Common Shares Outstanding | 49.07 | 47.65 | 46.35 | 41.18 | 40.09 | 39.2 | Upgrade
|
Working Capital | 46.42 | 56.8 | 56.8 | 30.44 | 31.88 | 75.46 | Upgrade
|
Book Value Per Share | 1.45 | 1.12 | 0.47 | -0.06 | -0.15 | 0.45 | Upgrade
|
Tangible Book Value | 17.52 | -7.43 | -49 | -68.57 | -80.09 | -23 | Upgrade
|
Tangible Book Value Per Share | 0.36 | -0.16 | -1.06 | -1.67 | -2.00 | -0.59 | Upgrade
|
Machinery | 4.8 | 4.76 | 4.79 | 4.84 | 4.85 | 5.38 | Upgrade
|
Leasehold Improvements | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.